Sequences

Sample result

Human insulin's gene

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

1,584 publications in 1,066 families match these filters.

  1. US 9200083-B22015-12-01

    Methods of treating diabetes using therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptides

    DUKE UNIVERSITY

    Query Match 77.5%Identity 100.0%

    Best alignment

    Query 73 to 330, hit 45 to 302. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 104
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 164
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 224
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 284
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   285 CTGGAGAACTACTGCAAC 302
    

    258 of 258 identical, no gaps.

  2. US 9328154-B22016-05-03

    Therapeutic agents comprising fusions of growth hormone and elastic peptides

    DUKE UNIVERSITY

    Query Match 77.5%Identity 100.0%

    Best alignment

    Query 73 to 330, hit 45 to 302. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 104
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 164
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 224
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 284
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   285 CTGGAGAACTACTGCAAC 302
    

    258 of 258 identical, no gaps.

  3. US 9458218-B22016-10-04

    Therapeutic agents comprising fusions of insulin and elastic peptides

    DUKE UNIVERSITY

    Query Match 77.5%Identity 100.0%

    Best alignment

    Query 73 to 330, hit 45 to 302. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 104
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 164
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 224
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 284
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   285 CTGGAGAACTACTGCAAC 302
    

    258 of 258 identical, no gaps.

  4. EP 3220936-A22017-09-27

    ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

    PHASEBIO PHARMACEUTICALS INC

    Query Match 77.5%Identity 100.0%Family of 4

    Best alignment and family

    Query 73 to 330, hit 4 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     4 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 63
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    64 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 123
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   124 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 183
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 243
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   244 CTGGAGAACTACTGCAAC 261
    

    258 of 258 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, US 62/082945.

  5. US 9821036-B22017-11-21

    Therapeutic agents comprising a GLP-2 peptide and elastin-like peptides

    DUKE UNIVERSITY

    Query Match 77.5%Identity 100.0%

    Best alignment

    Query 73 to 330, hit 45 to 302. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 104
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 164
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 224
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 284
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   285 CTGGAGAACTACTGCAAC 302
    

    258 of 258 identical, no gaps.

  6. US 10596230-B22020-03-24

    Methods of increasing nutrient absorption in the intestine using therapeutic agents comprising GLP-2 and elastin-like peptides

    DUKE UNIVERSITY

    Query Match 77.5%Identity 100.0%

    Best alignment

    Query 73 to 330, hit 45 to 302. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 104
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 164
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 224
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 284
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   285 CTGGAGAACTACTGCAAC 302
    

    258 of 258 identical, no gaps.

  7. US 11103558-B22021-08-31

    Therapeutic agents comprising a BMP-9 peptide and eleastin-like peptides

    Duke University

    Query Match 77.5%Identity 100.0%

    Best alignment

    Query 73 to 330, hit 45 to 302. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    45 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 104
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   105 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 164
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   165 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 224
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   225 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 284
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   285 CTGGAGAACTACTGCAAC 302
    

    258 of 258 identical, no gaps.

  8. EP 2318432-A22011-05-11

    HALOGEN-STABILIZED INSULIN

    UNIV CASE WESTERN RESERVE

    Query Match 76.9%Identity 99.2%Family of 2

    Best alignment and family

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTAGACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    259 of 261 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  9. HALOGEN-STABILIZED INSULIN

    CASE WESTERN RESERVE UNIVERSITY

    Query Match 76.9%Identity 99.2%Family of 4

    Best alignment and family

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTAGACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    259 of 261 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, US 61/085212.

  10. US 9200053-B22015-12-01

    Insulin analogues containing penta-fluoro-Phenylalanine at position B24

    Case Western Reserve University

    Query Match 76.9%Identity 99.2%

    Best alignment

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTAGACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    259 of 261 identical, no gaps.

  11. JP 1999341991-A1999-12-14

    DNA encoding novel fused protein and process for producing useful protein mediating the expression thereof

    ITO HAM KK,JUZO UDAKA

    Query Match 76.7%Identity 99.6%

    Best alignment

    Query 73 to 330, hit 133 to 390. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   133 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 192
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   193 GAAAGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 252
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   253 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 312
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   313 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 372
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   373 CTGGAGAACTACTGCAAC 390
    

    257 of 258 identical, no gaps.

  12. US 6506595-A2003-01-14

    DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs

    Itoham Foods Inc.

    Query Match 76.7%Identity 99.6%

    Best alignment

    Query 73 to 330, hit 133 to 390. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   133 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 192
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   193 GAAAGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 252
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   253 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 312
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   313 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 372
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   373 CTGGAGAACTACTGCAAC 390
    

    257 of 258 identical, no gaps.

  13. Ramp Tag for Overexpressing Insulin and Method for Producing Insulin Using the Same

    POLUS Inc

    Query Match 76.6%Identity 100.0%

    Best alignment

    Query 73 to 327, hit 1 to 255. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGC 327
              |||||||||||||||
    Hit   241 CTGGAGAACTACTGC 255
    

    255 of 255 identical, no gaps.

  14. LIQUID INSULIN- CONTAINING COMPOSITIONS AND METHODS OF MAKING THE SAME

    ELONA BIOTECHNOLOGIES

    Query Match 76.4%Identity 98.9%

    Best alignment

    Query 72 to 333, hit 33 to 294. Positions start at 1 and include both ends.

    Query  72 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 131
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    33 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 92
    
    Query 132 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 191
              |||||||||||||||||||||||| |||||||||||||||||||||||||||||||||||
    Hit    93 GGAACGAGGCTTCTTCTACACACCGAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 152
    
    Query 192 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 251
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   153 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 212
    
    Query 252 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 311
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   213 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 272
    
    Query 312 GCTGGAGAACTACTGCAACTAG 333
              ||||||||||||||||  ||||
    Hit   273 GCTGGAGAACTACTGCGGCTAG 294
    

    259 of 262 identical, no gaps.

  15. US 5446020-A1995-08-29

    Method of treating diabetes with tissue-selective insulin analogs

    Query Match 76.1%Identity 100.0%

    Best alignment

    Query 73 to 333, hit 244 to 504. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              |||||||||||||||||||| || || |||||||||||||||||||||||||||||||||
    Hit   244 TTTGTGAACCAACACCTGTGTGGATCCCACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 303
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   304 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 363
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   364 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 423
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   424 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 483
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   484 CTGGAGAACTACTGCAACTAG 504
    

    258 of 261 identical, no gaps.

  16. EP 2509995-A22012-10-17

    INSULIN ANALOGUES WITH CHLORINATED AMINO ACIDS

    UNIV CASE WESTERN RESERVE

    Query Match 76.1%Identity 98.9%

    Best alignment

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    258 of 261 identical, no gaps.

  17. INSULIN ANALOGUES WITH CHLORINATED AMINO ACIDS

    CASE WESTERN RESERVE UNIVERSITY

    Query Match 76.1%Identity 98.9%Family of 3

    Best alignment and family

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    258 of 261 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  18. US 8399407-B22013-03-19

    Non-standard insulin analogues

    Case Western Reserve University

    Query Match 76.1%Identity 98.9%Family of 5

    Best alignment and family

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    258 of 261 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  19. JP 2014533241-A2014-12-11

    ULTRA-CONCENTRATED RAPID-ACTING INSULIN ANALOGUE FORMULATIONS

    Case Western Reserve University,Michael A Weiss

    Query Match 76.1%Identity 98.9%

    Best alignment

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    258 of 261 identical, no gaps.

  20. ULTRA-CONCENTRATED RAPID-ACTING INSULIN ANALOGUE FORMULATIONS

    CASE WESTERN RESERVE UNIVERSITY

    Query Match 76.1%Identity 98.9%Family of 2

    Best alignment and family

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    258 of 261 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  21. US 9758563-B22017-09-12

    Insulin analogues with chlorinated amino acids and nucleic acids encoding the same

    Case Western Reserve University

    Query Match 76.1%Identity 98.9%

    Best alignment

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    258 of 261 identical, no gaps.

  22. ASPART PROINSULIN COMPOSITIONS AND METHODS OF PRODUCING ASPART INSULIN ANALOGS

    ELONA BIOTECHNOLOGIES

    Query Match 75.7%Identity 98.5%

    Best alignment

    Query 72 to 333, hit 445 to 706. Positions start at 1 and include both ends.

    Query  72 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 131
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   445 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 504
    
    Query 132 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 191
              ||||||||||||||||||||||  ||||||||||||||||||||||||||||||||||||
    Hit   505 GGAACGAGGCTTCTTCTACACAGACAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 564
    
    Query 192 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 251
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   565 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 624
    
    Query 252 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 311
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   625 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 684
    
    Query 312 GCTGGAGAACTACTGCAACTAG 333
              ||||||||||||||||  ||||
    Hit   685 GCTGGAGAACTACTGCGGCTAG 706
    

    258 of 262 identical, no gaps.

  23. GLARGINE PROINSULIN COMPOSITIONS AND METHODS OF PRODUCING GLARGINE INSULIN ANALOGS THEREFROM

    ELONA BIOTECHNOLOGIES

    Query Match 75.7%Identity 98.5%

    Best alignment

    Query 72 to 333, hit 445 to 706. Positions start at 1 and include both ends.

    Query  72 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 131
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   445 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 504
    
    Query 132 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 191
              |||||||||||||||||||||||| || ||||||||||||||||||||||||||||||||
    Hit   505 GGAACGAGGCTTCTTCTACACACCGAACACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 564
    
    Query 192 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 251
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   565 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 624
    
    Query 252 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 311
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   625 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 684
    
    Query 312 GCTGGAGAACTACTGCAACTAG 333
              ||||||||||||||||  ||||
    Hit   685 GCTGGAGAACTACTGCGGCTAG 706
    

    258 of 262 identical, no gaps.

  24. JP 2000116392-A2000-04-25

    Novel vector

    PFIZER INC

    Query Match 74.9%Identity 98.1%

    Best alignment

    Query 72 to 333, hit 4 to 265. Positions start at 1 and include both ends.

    Query  72 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 131
              |||||||||||||||||||||||| || |||||||||||||||||| |||||||||||||
    Hit     4 CTTTGTGAACCAACACCTGTGCGGATCCCACCTGGTGGAAGCTCTCCACCTAGTGTGCGG 63
    
    Query 132 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 191
              |||||||||||||||||||||||||||||||||||||  |||||||||||||||||||||
    Hit    64 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGAGGGCAGAGGACCTGCAGGTGGG 123
    
    Query 192 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 251
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   124 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 183
    
    Query 252 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 311
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   184 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 243
    
    Query 312 GCTGGAGAACTACTGCAACTAG 333
              ||||||||||||||||||||||
    Hit   244 GCTGGAGAACTACTGCAACTAG 265
    

    257 of 262 identical, no gaps.

  25. EP 3356525-A12018-08-08

    COMPOSITIONS FOR ADJUSTABLE RIBOSOME TRANSLATION SPEED AND METHODS OF USE

    UNIV UTAH RES FOUND

    Query Match 74.9%Identity 98.1%

    Best alignment

    Query 72 to 333, hit 30 to 291. Positions start at 1 and include both ends.

    Query  72 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 131
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    30 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 89
    
    Query 132 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 191
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    90 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 149
    
    Query 192 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 251
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   150 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 209
    
    Query 252 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 311
              ||| ||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   210 GTCTCTGCAGGCGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 269
    
    Query 312 GCTGGAGAACTACTGCAACTAG 333
              ||||||||||||||||  ||||
    Hit   270 GCTGGAGAACTACTGCGGCTAG 291
    

    257 of 262 identical, no gaps.

  26. JP 2018529365-A2018-10-11

    COMPOSITIONS FOR ADJUSTABLE RIBOSOME TRANSLATION SPEED AND METHODS OF USE

    UNIVERSITY OF UTAH RESEARCH FOUNDATION

    Query Match 74.9%Identity 98.1%Family of 2

    Best alignment and family

    Query 72 to 333, hit 30 to 291. Positions start at 1 and include both ends.

    Query  72 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 131
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    30 CTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGG 89
    
    Query 132 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 191
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    90 GGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGG 149
    
    Query 192 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 251
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   150 GCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGG 209
    
    Query 252 GTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 311
              ||| ||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   210 GTCTCTGCAGGCGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCA 269
    
    Query 312 GCTGGAGAACTACTGCAACTAG 333
              ||||||||||||||||  ||||
    Hit   270 GCTGGAGAACTACTGCGGCTAG 291
    

    257 of 262 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  27. N-TERMINAL TRUNCATED INSULIN ANALOGUES

    CASE WESTERN RESERVE UNIVERSITY

    Query Match 74.3%Identity 97.7%Family of 3

    Best alignment and family

    Query 73 to 333, hit 1 to 261. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              |||||   ||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 TTTGTNNNCCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||  ||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTAGTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGCGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACTAG 333
              |||||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACTAG 261
    

    255 of 261 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  28. Novel insulin analog and use thereof

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 3

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, KR 10-2014-0006937.

  29. long acting insulin and use thereof

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 3

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  30. Composition for Treating Diabetes Comprising Long-acting Insulin Analogue Conjugate and Long-acting Insulinotropic Peptide Conjugate

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 3

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  31. Composition for Treating Diabetes Mellitus Comprising Insulin and a GLP-1/glucagon dual agonist

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 2

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  32. Insulin analog

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  33. Novel Insulin Analogs and use thereof

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 2

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  34. Method of insulin production

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 2

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  35. EP 3148571-A12017-04-05

    COMPOSITION FOR TREATING DIABETES MELLITUS COMPRISING INSULIN AND A GLP-1/GLUCAGON DUAL AGONIST

    HANMI PHARM IND CO LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  36. EP 3156066-A12017-04-19

    COMPOSITION FOR TREATING DIABETES, CONTAINING LONG-ACTING INSULIN ANALOG CONJUGATE AND LONG-ACTING INSULIN SECRETION PEPTIDE CONJUGATE

    HANMI PHARM IND CO LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  37. EP 3341404-A12018-07-04

    NOVEL INSULIN ANALOGS AND USE THEREOF

    HANMI PHARM IND CO LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  38. EP 3341405-A12018-07-04

    METHOD OF INSULIN PRODUCTION

    HANMI PHARM IND CO LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  39. US 10017557-B22018-07-10

    Insulin analogs and use thereof

    HANMI PHARM. CO., LTD.

    Query Match 74.0%Identity 98.1%Family of 2

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  40. US 10159715-B22018-12-25

    Method for treating diabetes comprising long-acting insulin analogue conjugate and long-acting insulinotropic peptide conjugate

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  41. US 10188703-B22019-01-29

    Method for treating diabetes mellitus by a composition comprising insulin and a GLP-1/glucagon dual agonist

    HANMI PHARM. CO., LTD.

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  42. A long acting protein complex having an enhanced efficiency

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 2

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  43. A pharmaceutical composition comprising insulin and trigonal glucagon/GLP-1/GIP receptor agonist

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 2

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  44. A pharmaceutical composition comprising insulin and glucagon

    HANMI PHARM. CO., LTD

    Query Match 74.0%Identity 98.1%Family of 3

    Best alignment and family

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, KR 10-2018-0167798.

  45. EP 3689914-A12020-08-05

    PERSISTENT PROTEIN CONJUGATE WITH IMPROVED EFFICIENCY

    HANMI PHARM IND CO LTD

    Query Match 74.0%Identity 98.1%

    Best alignment

    Query 73 to 331, hit 1 to 259. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCAACCAG 240
    
    Query 313 CTGGAGAACTACTGCAACT 331
              |||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAACT 259
    

    254 of 259 identical, no gaps.

  46. A conjugate of insulin analog with reduced affinity to insulin receptor and use thereof

    HANMI PHARM. CO., LTD

    Query Match 73.7%Identity 98.1%Family of 4

    Best alignment and family

    Query 73 to 330, hit 1 to 258. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCGACCAG 240
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAAC 258
    

    253 of 258 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, KR 10-2017-0037101.

  47. EP 3517544-A12019-07-31

    INSULIN ANALOG HAVING REDUCED BINDING FORCE TO INSULIN RECEPTOR, AND USE THEREOF

    HANMI PHARM IND CO LTD

    Query Match 73.7%Identity 98.1%

    Best alignment

    Query 73 to 330, hit 1 to 258. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCGACCAG 240
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAAC 258
    

    253 of 258 identical, no gaps.

  48. JP 2019531075-A2019-10-31

    INSULIN ANALOG HAVING REDUCED BINDING FORCE TO INSULIN RECEPTOR, AND USE THEREOF

    HANMI PHARM CO LTD,Sanofi-Aventis Deutschland GmbH

    Query Match 73.7%Identity 98.1%

    Best alignment

    Query 73 to 330, hit 1 to 258. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCGACCAG 240
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAAC 258
    

    253 of 258 identical, no gaps.

  49. EP 3604328-A22020-02-05

    INSULIN ANALOG COMPLEX WITH REDUCED AFFINITY FOR INSULIN RECEPTOR AND USE THEREOF

    HANMI PHARM IND CO LTD

    Query Match 73.7%Identity 98.1%

    Best alignment

    Query 73 to 330, hit 1 to 258. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCGACCAG 240
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAAC 258
    

    253 of 258 identical, no gaps.

  50. US 11396534-B22022-07-26

    Insulin analogs with reduced affinity to insulin receptor and use thereof

    HANMI PHARM. CO., LTD. and SANOFI-AVENTIS DEUTSCHLAND GMBH

    Query Match 73.7%Identity 98.1%

    Best alignment

    Query 73 to 330, hit 1 to 258. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||||||| |||| |||||||||||||||||||||||||||||||||||||||
    Hit     1 TTCGTTAACCAACACTTGTGTGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 192
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    61 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGG 120
    
    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit   121 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 180
    
    Query 253 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAG 312
              |||||||||||||||||||||||||||||||||||||||||||||||||||||| |||||
    Hit   181 TCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCGACCAG 240
    
    Query 313 CTGGAGAACTACTGCAAC 330
              ||||||||||||||||||
    Hit   241 CTGGAGAACTACTGCAAC 258
    

    253 of 258 identical, no gaps.